Literature DB >> 8726168

Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.

H Sassa1, T Sone, H Tsuboi, J Kondo, T Yabashi.   

Abstract

Thrombin-antithrombin III (TAT) and D-dimer were measured in 50 patients suspected of deep venous thrombosis (DVT) to assess the usefulness of these indicators in the diagnosis of DVT. DVT was diagnosed by ultrasonography (compression method and Doppler imaging). In patients who were negative for DVT (Group A), TAT was 3.8 +/- 2.36 micrograms/L (mean +/- SD) and D-dimer was 0.7 +/- 0.69 micrograms/ml, whereas in patients diagnosed with DVT (Group B), TAT was 20.4 +/- 19.10 micrograms/L (p < 0.001) and D-dimer was 9.0 +/- 9.21 micrograms/ml (p < 0.001). Thus, Group B had significantly higher levels of both markers. Moreover, 19 of the 23 cases in Group B had acute DVT, with symptoms appearing within 2 weeks of onset. When the cutoff for a positive diagnosis of DVT was set at TAT of 7.0 micrograms/L or more and D-dimer of 3.0 micrograms/ml or more, sensitivity was 84%, specificity was 96%, and accuracy was 90%. Based on these results, we concluded that TAT and D-dimer are extremely useful in screening for acute DVT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726168     DOI: 10.1253/jcj.60.201

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  3 in total

1.  Rapid occurrence of left ventricular thrombus associated with platinum-based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report.

Authors:  Atsushi Ikeda; Eiki Yamachika; Masahide Mizutani; Masakazu Matsubara; Norifumi Moritani; Kazuki Nakatsuji; Seiji Iida
Journal:  Mol Clin Oncol       Date:  2017-08-25

2.  Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial.

Authors:  Sian Robinson; Aleksander Zincuk; Thomas Strøm; Torben Bjerregaard Larsen; Bjarne Rasmussen; Palle Toft
Journal:  Crit Care       Date:  2010-03-18       Impact factor: 9.097

3.  Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.

Authors:  Elena Y Senchenkova; Junaid Ansari; Felix Becker; Shantel A Vital; Zaki Al-Yafeai; Erica M Sparkenbaugh; Rafal Pawlinski; Karen Y Stokes; Jennifer L Carroll; Ana-Maria Dragoi; Cheng Xue Qin; Rebecca H Ritchie; Hai Sun; Hugo H Cuellar-Saenz; Mara R Rubinstein; Yiping W Han; A Wayne Orr; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.